McKesson Ventures, LLC - 13 Dec 2022 Form 4 Insider Report for Augmedix, Inc.

Signature
/s/ David Schulte, Senior Vice President and Managing Director of MCKESSON VENTURES, LLC
Issuer symbol
N/A
Transactions as of
13 Dec 2022
Net transactions value
-$2,530,500
Form type
4
Filing time
15 Dec 2022, 15:10:24 UTC
Previous filing
06 Oct 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Sale $2,530,500 -2,410,000 -61% $1.05* 1,572,432 13 Dec 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

McKesson Ventures, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.